In this case, Xstrahl 100 was used to treat basal cell carcinoma on the forehead and temple of a patient.
Basal Cell Carcinoma Case Study
read more
Resources
Xstrahl in Action: Multi-Disciplinary Management of Non-Melanoma Skin Cancer
In this video, Dr. Bernad, of Disney Family Cancer Center, discusses his experiences using the Xstrahl 100 device for treating skin cancer. https://vimeo.com/718400345 This was recorded at Hope Cancer Center and comes from the website of Providence Health &...
Bowen’s Disease Case Study
Xstrahl 150 was used to treat Bowen's disease with a forehead lesion with no additional loss of hair or negative cosmetic impact.
Lentigo Meligna Case Study
Xstrahl 150 was successfully used to treat lentigo maligna with normal visual acuity post treatment and improved cosmesis.
Cutaneous Squamous Cell Carcinoma Case Study
In this case study, Xstrahl 150 was used to treat two patients with Cutaneous Squamous Cell Carcinoma.
Xstrahl in Action: SARRP Utilized in Laboratory Microbeam Radiation
Microbeam radiation is typically only available at large synchrotron facilities. SARRP brings this research into a regular laboratory, enabling researchers to study open physics and biology questions in this emerging field. See the results of this study, Evaluation of...
Treating the Nasal Ala with Superficial Radiotherapy
Nasal function and cosmesis are important considerations in the quality of life for nasal ala skin cancer patients. Surgery involves tissue loss, which is likely to lead to impaired function and undesired cosmetic results. Superficial radiotherapy can be an effective...
Xstrahl in Action: SARRP Modified for MBRT Experiments
In this study, Minibeam Radiation Therapy at a Conventional Irradiator: Dose-Calculation Engine and First Tumor-Bearing Animals Irradiation, SARRP was modified to be adjustable for MBRT experiments. Researchers had the chance to conduct systematic and comprehensive...
Xstrahl in Action: SARRP Assists in EPR-Mediated Tumor Targeting
[:us]In the study, EPR-Mediated Tumor Targeting using Ultrasmall-hybrid Nanoparticles: From Animal to Human with Theranostic AGuIX Nanoparticles, SARRP was used to experience the therapeutic action of enhanced permeability and retention (EPR)-mediated tumor targeting...
Contact Us